- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00117273
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
May 8, 2014 updated by: Duramed Research
A Prospective, Single-Center, Open-Label, Randomized Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Regimens of Oral Contraceptive Pills
This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs).
Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03
mg for 84 days followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0.15/0.03
mg for 84 days followed by 7 days of ethinyl estradiol 0.01 mg), and a 28-day regimen OC, Portia (levonorgestrel/ethinyl estradiol 0.15/0.03
mg for 21 days followed by 7 days of placebo).
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Anticipated)
36
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Temple, Texas, United States, 76508
- Duramed Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 33 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Premenopausal
- Not pregnant or breastfeeding
- Weight <200 lbs
- Currently taking oral contraceptives in the standard 28-day regimen for at least two months
Exclusion Criteria:
- Any contraindication to the use of oral contraceptives
- Pregnancy within the last 3 months
- Smoking > 10 cigarettes per day
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
|
1 tablet daily
|
Active Comparator: 2
|
1 tablet daily
|
Active Comparator: 3
|
1 tablet daily x 28 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Compare differences in hormone patterns (follicle stimulating hormone [FSH], luteinizing hormone [LH], inhibin-B, and estradiol)
Time Frame: Before, during and after the 7-day hormone free interval or EE-supplemented interval
|
Before, during and after the 7-day hormone free interval or EE-supplemented interval
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Compare the differences in hormone withdrawal symptoms
Time Frame: Before, during and after the 7-day hormone free interval or EE-supplemented interval
|
Before, during and after the 7-day hormone free interval or EE-supplemented interval
|
Compare differences in ovarian follicular development
Time Frame: Before, during and after the 7-day hormone free interval or EE-supplemented intervals
|
Before, during and after the 7-day hormone free interval or EE-supplemented intervals
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Completion
June 1, 2006
Study Registration Dates
First Submitted
June 30, 2005
First Submitted That Met QC Criteria
June 30, 2005
First Posted (Estimate)
July 6, 2005
Study Record Updates
Last Update Posted (Estimate)
May 9, 2014
Last Update Submitted That Met QC Criteria
May 8, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Endocrine System Diseases
- Hypothalamic Diseases
- Pituitary Diseases
- Physiological Effects of Drugs
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Estrogens
- Contraceptive Agents, Hormonal
- Contraceptive Agents
- Reproductive Control Agents
- Contraceptives, Oral
- Contraceptive Agents, Female
- Contraceptives, Oral, Synthetic
- Contraceptives, Oral, Hormonal
- Levonorgestrel
- Estradiol
- Ethinyl Estradiol
Other Study ID Numbers
- DR PSE 310
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Seasonique (LNG/EE and EE)
-
AstraZenecaParexelCompleted
-
Organon and CoCompleted
-
Duramed ResearchCompletedDysmenorrheaUnited States
-
University of California, DavisWashington University School of MedicineTerminatedUterine Bleeding Heavy | Abnormal Uterine Bleeding, UnspecifiedUnited States
-
Duramed ResearchCompletedContraceptionUnited States
-
Duramed ResearchCompletedDysmenorrheaUnited States
-
St George's, University of LondonNeovii BiotechWithdrawnMitochondrial Diseases | Inborn Errors of Metabolism | Metabolic Disease
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
-
GlaxoSmithKlineWithdrawn